Major Estimate Revision • Jul 07
Consensus EPS estimates increase by 156% The consensus outlook for fiscal year 2026 has been updated. 2026 EPS estimate increased from CN¥0.34 to CN¥0.87. Revenue forecast steady at CN¥129.4b. Net income forecast to grow 327% next year vs 53% growth forecast for Chemicals industry in China. Consensus price target of CN¥13.40 unchanged from last update. Share price rose 8.6% to CN¥12.43 over the past week. Valuation Update With 7 Day Price Move • Jul 06
Investor sentiment improves as stock rises 11% After last week's 11% share price gain to CN¥12.55, the stock trades at a forward P/E ratio of 32x. Average forward P/E is 21x in the Chemicals industry in China. Total returns to shareholders of 6.3% over the past three years. New Risk • Jul 06
New major risk - Revenue and earnings growth Earnings have declined by 58% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.1x net interest cover). Earnings have declined by 58% per year over the past 5 years. Minor Risk Large one-off items impacting financial results. Announcement • Jun 30
Jiangsu Eastern Shenghong Co.,Ltd. to Report First Half, 2026 Results on Aug 29, 2026 Jiangsu Eastern Shenghong Co.,Ltd. announced that they will report first half, 2026 results on Aug 29, 2026 Reported Earnings • Apr 29
First quarter 2026 earnings released: EPS: CN¥0.22 (vs CN¥0.05 in 1Q 2025) First quarter 2026 results: EPS: CN¥0.22 (up from CN¥0.05 in 1Q 2025). Revenue: CN¥32.0b (up 5.7% from 1Q 2025). Net income: CN¥1.43b (up 320% from 1Q 2025). Profit margin: 4.5% (up from 1.1% in 1Q 2025). Revenue is forecast to grow 19% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 42% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings. Announcement • Apr 29
Jiangsu Eastern Shenghong Co.,Ltd., Annual General Meeting, May 21, 2026 Jiangsu Eastern Shenghong Co.,Ltd., Annual General Meeting, May 21, 2026, at 14:30 China Standard Time. Location: No. 289, Dengzhou Road, Shengze Town, Wujiang District, Suzhou, Jiangsu China Announcement • Mar 31
Jiangsu Eastern Shenghong Co.,Ltd. to Report Q1, 2026 Results on Apr 29, 2026 Jiangsu Eastern Shenghong Co.,Ltd. announced that they will report Q1, 2026 results on Apr 29, 2026 Board Change • Mar 01
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 10 experienced directors. 2 highly experienced directors. Non-Independent Director Xiaowei Yang was the last director to join the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. Announcement • Dec 31
Jiangsu Eastern Shenghong Co.,Ltd. to Report Fiscal Year 2025 Results on Apr 29, 2026 Jiangsu Eastern Shenghong Co.,Ltd. announced that they will report fiscal year 2025 results on Apr 29, 2026 New Risk • Nov 08
New major risk - Revenue and earnings growth Earnings have declined by 56% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.5x net interest cover). Earnings have declined by 56% per year over the past 5 years. Reported Earnings • Oct 31
Third quarter 2025 earnings released: CN¥0.043 loss per share (vs CN¥0.23 loss in 3Q 2024) Third quarter 2025 results: CN¥0.043 loss per share (improved from CN¥0.23 loss in 3Q 2024). Revenue: CN¥31.2b (down 12% from 3Q 2024). Net loss: CN¥259.8m (loss narrowed 85% from 3Q 2024). Revenue is forecast to grow 25% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 89 percentage points per year, which is a significant difference in performance. New Risk • Oct 31
New major risk - Revenue and earnings growth Earnings have declined by 58% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.2x net interest cover). Earnings have declined by 58% per year over the past 5 years. Price Target Changed • Sep 01
Price target increased by 14% to CN¥10.20 Up from CN¥8.97, the current price target is an average from 2 analysts. New target price is approximately in line with last closing price of CN¥9.87. Stock is up 28% over the past year. The company is forecast to post earnings per share of CN¥0.39 next year compared to a net loss per share of CN¥0.35 last year. Reported Earnings • Sep 01
Second quarter 2025 earnings released: EPS: CN¥0.007 (vs CN¥0.011 in 2Q 2024) Second quarter 2025 results: EPS: CN¥0.007 (down from CN¥0.011 in 2Q 2024). Revenue: CN¥30.6b (down 15% from 2Q 2024). Net income: CN¥45.1m (down 37% from 2Q 2024). Profit margin: 0.1% (down from 0.2% in 2Q 2024). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 19% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 95 percentage points per year, which is a significant difference in performance. Board Change • Aug 28
High number of new directors There are 5 new directors who have joined the board in the last 3 years. Non-Independent Director Xiaowei Yang was the last director to join the board, commencing their role in 2023. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Announcement • Jul 02
Jiangsu Eastern Shenghong Co.,Ltd. to Report First Half, 2025 Results on Aug 30, 2025 Jiangsu Eastern Shenghong Co.,Ltd. announced that they will report first half, 2025 results on Aug 30, 2025 Reported Earnings • Apr 29
First quarter 2025 earnings released: EPS: CN¥0.05 (vs CN¥0.04 in 1Q 2024) First quarter 2025 results: EPS: CN¥0.05 (up from CN¥0.04 in 1Q 2024). Revenue: CN¥30.3b (down 18% from 1Q 2024). Net income: CN¥341.2m (up 38% from 1Q 2024). Profit margin: 1.1% (up from 0.7% in 1Q 2024). The increase in margin was driven by lower expenses. Revenue is forecast to grow 14% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 106 percentage points per year, which is a significant difference in performance. Announcement • Apr 29
Jiangsu Eastern Shenghong Co.,Ltd., Annual General Meeting, May 21, 2025 Jiangsu Eastern Shenghong Co.,Ltd., Annual General Meeting, May 21, 2025, at 14:00 China Standard Time. Announcement • Mar 31
Jiangsu Eastern Shenghong Co.,Ltd. to Report Q1, 2025 Results on Apr 29, 2025 Jiangsu Eastern Shenghong Co.,Ltd. announced that they will report Q1, 2025 results on Apr 29, 2025 Announcement • Dec 31
Jiangsu Eastern Shenghong Co.,Ltd. to Report Fiscal Year 2024 Results on Apr 29, 2025 Jiangsu Eastern Shenghong Co.,Ltd. announced that they will report fiscal year 2024 results on Apr 29, 2025 Price Target Changed • Dec 18
Price target decreased by 10% to CN¥8.75 Down from CN¥9.72, the current price target is an average from 3 analysts. New target price is approximately in line with last closing price of CN¥8.75. Stock is up 1.0% over the past year. The company is forecast to post a net loss per share of CN¥0.16 compared to earnings per share of CN¥0.11 last year. Price Target Changed • Nov 04
Price target decreased by 11% to CN¥9.72 Down from CN¥10.88, the current price target is an average from 5 analysts. New target price is 20% above last closing price of CN¥8.07. Stock is down 24% over the past year. The company is forecast to post a net loss per share of CN¥0.14 compared to earnings per share of CN¥0.11 last year. Reported Earnings • Oct 31
Third quarter 2024 earnings: EPS and revenues miss analyst expectations Third quarter 2024 results: CN¥0.23 loss per share (down from CN¥0.12 profit in 3Q 2023). Revenue: CN¥35.5b (down 6.0% from 3Q 2023). Net loss: CN¥1.74b (down 318% from profit in 3Q 2023). Revenue missed analyst estimates by 16%. Earnings per share (EPS) were also behind analyst expectations. Revenue is forecast to grow 5.7% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 72 percentage points per year, which is a significant difference in performance. Announcement • Sep 30
Jiangsu Eastern Shenghong Co.,Ltd. to Report Q3, 2024 Results on Oct 31, 2024 Jiangsu Eastern Shenghong Co.,Ltd. announced that they will report Q3, 2024 results on Oct 31, 2024 Reported Earnings • Aug 30
Second quarter 2024 earnings: EPS and revenues miss analyst expectations Second quarter 2024 results: EPS: CN¥0.011 (down from CN¥0.14 in 2Q 2023). Revenue: CN¥36.1b (flat on 2Q 2023). Net income: CN¥71.7m (down 93% from 2Q 2023). Profit margin: 0.2% (down from 2.6% in 2Q 2023). Revenue missed analyst estimates by 23%. Earnings per share (EPS) also missed analyst estimates by 95%. Revenue is forecast to grow 4.7% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 42 percentage points per year, which is a significant difference in performance. Announcement • Jun 29
Jiangsu Eastern Shenghong Co.,Ltd. to Report First Half, 2024 Results on Aug 30, 2024 Jiangsu Eastern Shenghong Co.,Ltd. announced that they will report first half, 2024 results on Aug 30, 2024 Board Change • Jun 11
High number of new and inexperienced directors There are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. 3 experienced directors. 2 highly experienced directors. Chairman of the Supervisory Board Gen Yuan Ni is the most experienced director on the board, commencing their role in 2014. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Major Estimate Revision • Jun 06
Consensus EPS estimates fall by 12% The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from CN¥154.8b to CN¥150.6b. EPS estimate also fell from CN¥0.547 per share to CN¥0.481 per share. Net income forecast to grow 1,554% next year vs 52% growth forecast for Chemicals industry in China. Consensus price target down from CN¥13.21 to CN¥11.65. Share price fell 5.5% to CN¥8.55 over the past week. Announcement • Jun 01
Jiangsu Eastern Shenghong Co.,Ltd. Announces 2023 Final Profit Distribution Plan to Be Implemented on A Shares, Payable on 07 June 2024 Jiangsu Eastern Shenghong Co.,Ltd. announced the 2023 final profit distribution plan to be implemented (A shares): Cash dividend (tax included) of CNY 1.00000000 per 10 shares. Record date is on 06 June 2024 with Ex-date is on 07 June 2024. Payment date is on 07 June 2024. Price Target Changed • May 06
Price target decreased by 7.5% to CN¥13.21 Down from CN¥14.28, the current price target is an average from 5 analysts. New target price is 30% above last closing price of CN¥10.15. Stock is down 19% over the past year. The company is forecast to post earnings per share of CN¥0.54 for next year compared to CN¥0.11 last year. Major Estimate Revision • May 06
Consensus EPS estimates fall by 41% The consensus outlook for fiscal year 2024 has been updated. 2024 EPS estimate fell from CN¥0.918 to CN¥0.54 per share. Revenue forecast steady at CN¥154.6b. Net income forecast to grow 1,770% next year vs 56% growth forecast for Chemicals industry in China. Consensus price target down from CN¥14.28 to CN¥13.21. Share price fell 2.0% to CN¥10.15 over the past week. Reported Earnings • Apr 26
Full year 2023 earnings released: EPS: CN¥0.11 (vs CN¥0.09 in FY 2022) Full year 2023 results: EPS: CN¥0.11 (up from CN¥0.09 in FY 2022). Revenue: CN¥140.4b (up 120% from FY 2022). Net income: CN¥717.0m (up 31% from FY 2022). Profit margin: 0.5% (down from 0.9% in FY 2022). Revenue is forecast to grow 9.1% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 37% per year but the company’s share price has only fallen by 13% per year, which means it has not declined as severely as earnings. Announcement • Mar 30
Jiangsu Eastern Shenghong Co.,Ltd. to Report Q1, 2024 Results on Apr 30, 2024 Jiangsu Eastern Shenghong Co.,Ltd. announced that they will report Q1, 2024 results on Apr 30, 2024 Announcement • Dec 30
Jiangsu Eastern Shenghong Co.,Ltd. to Report Fiscal Year 2023 Results on Apr 26, 2024 Jiangsu Eastern Shenghong Co.,Ltd. announced that they will report fiscal year 2023 results on Apr 26, 2024 Reported Earnings • Oct 29
Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind Third quarter 2023 results: EPS: CN¥0.12 (up from CN¥0.009 loss in 3Q 2022). Revenue: CN¥37.7b (up 129% from 3Q 2022). Net income: CN¥798.2m (up CN¥857.0m from 3Q 2022). Profit margin: 2.1% (up from net loss in 3Q 2022). Revenue exceeded analyst estimates by 6.8%. Earnings per share (EPS) missed analyst estimates by 65%. Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 18% per year but the company’s share price has increased by 20% per year, which means it is well ahead of earnings. Price Target Changed • Aug 19
Price target decreased by 7.3% to CN¥16.76 Down from CN¥18.08, the current price target is an average from 6 analysts. New target price is 44% above last closing price of CN¥11.61. Stock is down 49% over the past year. The company is forecast to post earnings per share of CN¥0.78 for next year compared to CN¥0.09 last year. Major Estimate Revision • Aug 17
Consensus EPS estimates fall by 36% The consensus outlook for earnings per share (EPS) in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from CN¥137.2b to CN¥129.0b. EPS estimate also fell from CN¥1.25 per share to CN¥0.802 per share. Net income forecast to grow 1,141% next year vs 48% growth forecast for Chemicals industry in China. Consensus price target broadly unchanged at CN¥17.85. Share price fell 5.7% to CN¥11.90 over the past week. Reported Earnings • Aug 11
Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind Second quarter 2023 results: EPS: CN¥0.14. Revenue: CN¥36.4b (up 121% from 2Q 2022). Net income: CN¥963.3m (up 1.6% from 2Q 2022). Profit margin: 2.6% (down from 5.8% in 2Q 2022). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 20%. Earnings per share (EPS) missed analyst estimates by 31%. Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Announcement • May 17
Jiangsu Eastern Shenghong Co.,Ltd. Announces Cash Dividend for 2022, Payable on 22 May 2023 Jiangsu Eastern Shenghong Co.,Ltd. announced cash dividend of CNY 1.00000000 per ten shares (tax included) for the year 2022, Record date: 19 May 2023, Ex-date: 22 May 2023 and Payment date is 22 May 2023. Price Target Changed • Apr 30
Price target decreased by 8.8% to CN¥18.74 Down from CN¥20.55, the current price target is an average from 5 analysts. New target price is 48% above last closing price of CN¥12.67. Stock is up 3.4% over the past year. The company is forecast to post earnings per share of CN¥1.43 for next year compared to CN¥0.09 last year. Price Target Changed • Apr 18
Price target decreased by 7.5% to CN¥19.80 Down from CN¥21.40, the current price target is an average from 4 analysts. New target price is 51% above last closing price of CN¥13.13. Stock is down 6.0% over the past year. The company is forecast to post earnings per share of CN¥1.52 for next year compared to CN¥0.09 last year. Reported Earnings • Apr 18
Full year 2022 earnings: EPS and revenues miss analyst expectations Full year 2022 results: EPS: CN¥0.09 (down from CN¥0.76 in FY 2021). Revenue: CN¥63.8b (up 23% from FY 2021). Net income: CN¥548.2m (down 88% from FY 2021). Profit margin: 0.9% (down from 8.8% in FY 2021). Revenue missed analyst estimates by 11%. Earnings per share (EPS) also missed analyst estimates by 57%. Revenue is forecast to grow 37% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has increased by 38% per year, which means it is tracking significantly ahead of earnings growth. Announcement • Feb 14
Jiangsu Eastern Shenghong Co., Ltd. Announces Board Appointments Jiangsu Eastern Shenghong Co., Ltd. held its 2nd Extraordinary General Meeting of 2023 on 10 February 2023 announced the appointment of Yang Xiaowei as non-independent directors. Xu Jinye and Ren Zhigang as independent directors. Yang Fangbin, Zhou Xuefeng and Jing Daoquan as supervisors. Major Estimate Revision • Feb 04
Consensus EPS estimates fall by 12% The consensus outlook for fiscal year 2022 has been updated. 2022 consensus EPS estimate fell from CN¥0.462 to CN¥0.407. Revenue forecast reaffirmed at CN¥73.9b. Net income forecast to grow 280% next year vs 41% growth forecast for Chemicals industry in China. Consensus price target of CN¥21.40 unchanged from last update. Share price rose 5.6% to CN¥15.50 over the past week. Announcement • Dec 29
Jiangsu Eastern Shenghong Co., Ltd. has completed a Follow-on Equity Offering in the amount of $784.9945 million. Jiangsu Eastern Shenghong Co., Ltd. has completed a Follow-on Equity Offering in the amount of $784.9945 million.
Security Name: Global Depository Reciepts
Security Type: Depositary Receipt (Common Stock)
Securities Offered: 43,490,000
Price\Range: $18.05
Transaction Features: New Market Listing; Regulation S Major Estimate Revision • Dec 06
Consensus EPS estimates fall by 31% The consensus outlook for earnings per share (EPS) in 2022 has deteriorated. 2022 revenue forecast decreased from CN¥79.8b to CN¥74.9b. EPS estimate also fell from CN¥0.68 per share to CN¥0.47 per share. Net income forecast to grow 287% next year vs 44% growth forecast for Chemicals industry in China. Consensus price target of CN¥21.40 unchanged from last update. Share price rose 6.3% to CN¥14.11 over the past week. Price Target Changed • Nov 16
Price target decreased to CN¥21.77 Down from CN¥24.92, the current price target is an average from 3 analysts. New target price is 59% above last closing price of CN¥13.70. Stock is down 41% over the past year. The company is forecast to post earnings per share of CN¥0.73 for next year compared to CN¥0.76 last year. Major Estimate Revision • Nov 04
Consensus EPS estimates fall by 21% The consensus outlook for earnings per share (EPS) in 2022 has deteriorated. 2022 revenue forecast decreased from CN¥87.2b to CN¥84.2b. EPS estimate also fell from CN¥1.04 per share to CN¥0.82 per share. Net income forecast to grow 361% next year vs 44% growth forecast for Chemicals industry in China. Consensus price target down from CN¥24.92 to CN¥21.77. Share price was steady at CN¥12.78 over the past week. Price Target Changed • Nov 03
Price target decreased to CN¥21.77 Down from CN¥24.92, the current price target is an average from 3 analysts. New target price is 70% above last closing price of CN¥12.78. Stock is down 45% over the past year. The company is forecast to post earnings per share of CN¥0.82 for next year compared to CN¥0.76 last year. Reported Earnings • Oct 30
Third quarter 2022 earnings released: CN¥0.009 loss per share (vs CN¥0.06 profit in 3Q 2021) Third quarter 2022 results: CN¥0.009 loss per share (down from CN¥0.06 profit in 3Q 2021). Revenue: CN¥16.5b (up 75% from 3Q 2021). Net loss: CN¥58.8m (down 121% from profit in 3Q 2021). Revenue is forecast to grow 32% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 28% per year but the company’s share price has increased by 35% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Oct 25
Investor sentiment deteriorated over the past week After last week's 16% share price decline to CN¥13.48, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 15x in the Chemicals industry in China. Total returns to shareholders of 164% over the past three years. Valuation Update With 7 Day Price Move • Sep 08
Investor sentiment improved over the past week After last week's 16% share price gain to CN¥21.73, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 17x in the Chemicals industry in China. Total returns to shareholders of 313% over the past three years. Price Target Changed • Aug 22
Price target increased to CN¥23.87 Up from CN¥21.17, the current price target is an average from 6 analysts. New target price is 9.3% above last closing price of CN¥21.84. Stock is down 13% over the past year. The company is forecast to post earnings per share of CN¥1.12 for next year compared to CN¥0.76 last year. Reported Earnings • Aug 21
Second quarter 2022 earnings released: EPS: CN¥0.16 (vs CN¥0.12 in 2Q 2021) Second quarter 2022 results: EPS: CN¥0.16 (up from CN¥0.12 in 2Q 2021). Revenue: CN¥16.5b (up 79% from 2Q 2021). Net income: CN¥947.8m (up 74% from 2Q 2021). Profit margin: 5.8% (in line with 2Q 2021). Over the next year, revenue is forecast to grow 94%, compared to a 41% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has increased by 64% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Jul 28
Investor sentiment improved over the past week After last week's 20% share price gain to CN¥20.06, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 17x in the Chemicals industry in China. Total returns to shareholders of 294% over the past three years. Valuation Update With 7 Day Price Move • Jun 13
Investor sentiment improved over the past week After last week's 19% share price gain to CN¥18.93, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 18x in the Chemicals industry in China. Total returns to shareholders of 245% over the past three years. Valuation Update With 7 Day Price Move • May 23
Investor sentiment improved over the past week After last week's 15% share price gain to CN¥16.02, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 16x in the Chemicals industry in China. Total returns to shareholders of 218% over the past three years. Announcement • May 21
Jiangsu Eastern Shenghong Co., Ltd. Announces Cash Dividend for A Shares for the Year 2021, Payment Date Is 27 May 2022 Jiangsu Eastern Shenghong Co., Ltd. announced cash dividend/10 shares (tax included) of CNY 1.50000000 for A shares for the year 2021. Record date is 26 May 2022. Ex-date is 27 May 2022. Payment date is 27 May 2022. Announcement • May 12
Jiangsu Eastern Shenghong Co., Ltd. Approves Final Cash Dividend for the Year 2021 Jiangsu Eastern Shenghong Co., Ltd. approved final cash dividend (tax included) of CNY 1.5000000 per 10 shares for the year 2021, at the AGM held on May 9, 2022. Major Estimate Revision • May 06
Consensus forecasts updated The consensus outlook for 2022 has been updated. 2022 revenue forecast fell from CN¥95.7b to CN¥79.3b. EPS estimate increased from CN¥1.30 to CN¥1.34 per share. Net income forecast to grow 115% next year vs 40% growth forecast for Chemicals industry in China. Consensus price target down from CN¥25.43 to CN¥21.92. Share price was steady at CN¥12.25 over the past week. Reported Earnings • May 02
First quarter 2022 earnings: EPS and revenues exceed analyst expectations First quarter 2022 results: EPS: CN¥0.12 (vs CN¥0.12 in 1Q 2021). Revenue: CN¥13.8b (up 113% from 1Q 2021). Net income: CN¥688.3m (up 14% from 1Q 2021). Profit margin: 5.0% (down from 9.3% in 1Q 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 36%. Earnings per share (EPS) also surpassed analyst estimates by 90%. Over the next year, revenue is forecast to grow 99%, compared to a 42% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 26% per year whereas the company’s share price has increased by 31% per year. Board Change • Apr 27
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 9 experienced directors. 3 highly experienced directors. 3 independent directors (4 non-independent directors). Independent Director Xiang Jian Zhang was the last independent director to join the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Announcement • Apr 22
Jiangsu Eastern Shenghong Co., Ltd., Annual General Meeting, May 09, 2022 Jiangsu Eastern Shenghong Co., Ltd., Annual General Meeting, May 09, 2022, at 14:00 China Standard Time. Agenda: To consider 2021 work report of the board of directors; to consider 2021 work report of the supervisory committee; to consider 2021 annual accounts and 2022 financial budget report; to consider 2021 profit distribution plan; to consider 2021 annual report and its summary; to consider Appointment of 2022 financial audit firm and internal control audit firm; and to consider Application for public issuance of green corporate bonds. Price Target Changed • Apr 20
Price target decreased to CN¥25.43 Down from CN¥28.40, the current price target is an average from 7 analysts. New target price is 91% above last closing price of CN¥13.34. Stock is down 12% over the past year. The company is forecast to post earnings per share of CN¥1.30 for next year compared to CN¥0.76 last year. Announcement • Apr 20
Jiangsu Eastern Shenghong Co., Ltd. Proposes Final Dividend for 2021 Jiangsu Eastern Shenghong Co., Ltd. proposed final dividend of CNY 1.50000000 per 10 shares (tax included) for 2021. Reported Earnings • Apr 19
Full year 2021 earnings: EPS and revenues exceed analyst expectations Full year 2021 results: EPS: CN¥0.76 (up from CN¥0.07 in FY 2020). Revenue: CN¥51.7b (up 127% from FY 2020). Net income: CN¥4.54b (up CN¥4.23b from FY 2020). Profit margin: 8.8% (up from 1.4% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 36%. Earnings per share (EPS) also surpassed analyst estimates by 90%. Over the next year, revenue is forecast to grow 94%, compared to a 49% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has increased by 31% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Mar 07
Investor sentiment deteriorated over the past week After last week's 17% share price decline to CN¥15.72, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 18x in the Chemicals industry in China. Total returns to shareholders of 177% over the past three years. Major Estimate Revision • Jan 11
Consensus EPS estimates increase by 60% The consensus outlook for earnings per share (EPS) in 2021 has improved. 2021 revenue forecast increased from CN¥34.2b to CN¥37.4b. EPS estimate increased from CN¥0.39 to CN¥0.62 per share. Net income forecast to grow 381% next year vs 41% growth forecast for Chemicals industry in China. Consensus price target of CN¥28.50 unchanged from last update. Share price was steady at CN¥19.45 over the past week. Major Estimate Revision • Jan 07
Consensus EPS estimates increase by 29% The consensus outlook for earnings per share (EPS) in 2021 has improved. 2021 revenue forecast increased from CN¥34.2b to CN¥34.9b. EPS estimate increased from CN¥0.39 to CN¥0.50 per share. Net income forecast to grow 348% next year vs 41% growth forecast for Chemicals industry in China. Consensus price target of CN¥28.50 unchanged from last update. Share price rose 6.0% to CN¥20.50 over the past week. Valuation Update With 7 Day Price Move • Dec 29
Investor sentiment deteriorated over the past week After last week's 17% share price decline to CN¥19.11, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 21x in the Chemicals industry in China. Total returns to shareholders of 269% over the past three years. Valuation Update With 7 Day Price Move • Nov 22
Investor sentiment improved over the past week After last week's 15% share price gain to CN¥24.21, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 362% over the past three years. Valuation Update With 7 Day Price Move • Nov 04
Investor sentiment deteriorated over the past week After last week's 16% share price decline to CN¥23.25, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 18x in the Chemicals industry in China. Total returns to shareholders of 330% over the past three years. Reported Earnings • Oct 31
Third quarter 2021 earnings released: EPS CN¥0.06 (vs CN¥0.04 in 3Q 2020) The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥9.39b (up 52% from 3Q 2020). Net income: CN¥283.3m (up 64% from 3Q 2020). Profit margin: 3.0% (up from 2.8% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 18% per year but the company’s share price has increased by 69% per year, which means it is well ahead of earnings. Reported Earnings • Aug 25
Second quarter 2021 earnings released: EPS CN¥0.12 (vs CN¥0.057 loss in 2Q 2020) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥9.23b (up 76% from 2Q 2020). Net income: CN¥546.0m (up CN¥680.0m from 2Q 2020). Profit margin: 5.9% (up from net loss in 2Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 24% per year but the company’s share price has increased by 66% per year, which means it is well ahead of earnings. Price Target Changed • Aug 18
Price target increased to CN¥25.10 Up from CN¥22.10, the current price target is an average from 5 analysts. New target price is 6.6% below last closing price of CN¥26.86. Stock is up 367% over the past year. Price Target Changed • Jul 14
Price target increased to CN¥22.10 Up from CN¥17.85, the current price target is an average from 6 analysts. New target price is 8.8% below last closing price of CN¥24.24. Stock is up 334% over the past year. Announcement • May 14
Jiangsu Eastern Shenghong Co., Ltd. announced a financing transaction Jiangsu Eastern Shenghong Co., Ltd. (SZSE:000301) announced a private placement of common shares on May 12, 2021. The transaction will include participation from not more than 35 specific investor. The issuance price will be not lower than 80% of the average price of the company’s shares as of 20 trading days since issuance date. The company will issue not more than 30% of the total share capital prior to the transaction. The shares issues will have a hold period of 6 months from the date of closing. The transaction has been approved by the board of directors of the company at is twenty-seventh meeting of the eighth directorate and is subject to shareholder and China Securities Regulatory Commission approvals. Reported Earnings • May 02
First quarter 2021 earnings released: EPS CN¥0.12 (vs CN¥0.05 in 1Q 2020) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: CN¥6.46b (up 53% from 1Q 2020). Net income: CN¥601.4m (up 205% from 1Q 2020). Profit margin: 9.3% (up from 4.7% in 1Q 2020). The increase in margin was driven by higher revenue. Reported Earnings • Apr 16
Full year 2020 earnings released: EPS CN¥0.07 (vs CN¥0.40 in FY 2019) The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥22.8b (down 8.5% from FY 2019). Net income: CN¥316.3m (down 80% from FY 2019). Profit margin: 1.4% (down from 6.5% in FY 2019). The decrease in margin was driven by lower revenue. Announcement • Feb 25
Jiangsu Eastern Shenghong Co., Ltd. to Report Fiscal Year 2020 Results on Apr 15, 2021 Jiangsu Eastern Shenghong Co., Ltd. announced that they will report fiscal year 2020 results on Apr 15, 2021 Is New 90 Day High Low • Feb 22
New 90-day high: CN¥16.08 The company is up 48% from its price of CN¥10.87 on 24 November 2020. The Chinese market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 18% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥1.75 per share. Is New 90 Day High Low • Jan 25
New 90-day high: CN¥15.55 The company is up 148% from its price of CN¥6.27 on 27 October 2020. The Chinese market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 25% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥1.75 per share. Is New 90 Day High Low • Jan 07
New 90-day high: CN¥11.44 The company is up 79% from its price of CN¥6.38 on 09 October 2020. The Chinese market is up 11% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 18% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥1.95 per share. Valuation Update With 7 Day Price Move • Jan 06
Investor sentiment improved over the past week After last week's 18% share price gain to CN¥10.79, the stock is trading at a trailing P/E ratio of 73.4x, up from the previous P/E ratio of 62.4x. This compares to an average P/E of 36x in the Chemicals industry in China. Total returns to shareholders over the past year are 111%. Valuation Update With 7 Day Price Move • Nov 24
Market bids up stock over the past week After last week's 17% share price gain to CN¥10.87, the stock is trading at a trailing P/E ratio of 74x, up from the previous P/E ratio of 63x. This compares to an average P/E of 40x in the Chemicals industry in China. Total returns to shareholders over the past year are 122%.